West Pharmaceutical Services | WST - Current Assets


West Pharmaceutical Services reported $1.81B in Current Assets for its fiscal quarter ending in June of 2026.





Current Assets Change Date
Align Technology USD 2.66B 7.62M Jun/2026
Baxter International USD 6.99B 142M Jun/2026
Becton, Dickinson and Co. USD 8.14B 127M Jun/2026
Cerus USD 174.38M 7.26M Dec/2025
Charles River Laboratories USD 1.53B 40.3M Jun/2026
Cooper Companies USD 2.28B 18.3M Jun/2026
Dentsply International USD 1.93B 83M Jun/2026
Haemonetics USD 810.83M 24.05M Jun/2026
ICU Medical USD 1.21B 2.34M Jun/2026
Insulet USD 1.85B 139.6M Jun/2026
Integra LifeSciences USD 1.19B 1.54M Sep/2026
IQVIA Holdings USD 6.23B 6M Jun/2026
J&J USD 56.35B 3.42B Sep/2026
Medtronic USD 24.39B 397M Jun/2026
Merit Medical Systems USD 1.11B 10.46M Jun/2026
Neogen USD 582.5M 22.1M Jun/2026
OraSure Technologies USD 222.94M 17.84M Jun/2026
Quidel USD 1.38B 400K Jun/2026
Repligen USD 1.2B 39.19M Jun/2026
Rockwell Medical USD 31.61M 1.42M Jun/2025
Solventum Corp USD 3.74B 158M Jun/2026
STAAR Surgical USD 342.35M 29.96M Jun/2026
Terumo JPY 906.6B 45.57B Jun/2026
Utah Medical Products USD 100.38M 2.64M Mar/2026
West Pharmaceutical Services USD 1.81B 19.3M Jun/2026